Plans & Pricing
Does My Company Subscribe?
For pharmaceutical companies, deploying programmatic technology is a sticky subject. Because of strict privacy and patient protection laws, pharma companies are limited in how they can target individual consumers, which makes programmatic advertising more of a guessing game. But that doesn’t mean it can’t be done. Jack Hogan, CTO at medical publisher Lifescript, spoke with eMarketer’s Maria Minsker about how pharma companies can use publishers’ data to leverage programmatic technology.
eMarketer: How can medical publishers create proxy audiences to power programmatic technology for pharma brands?
Jack Hogan: Medical publishers have vast audiences of opt-in consumers with targetable IDs and declared health interests. We’re talking about first-party data, not third-party health and medical data, which is inaccurate 50% of the time. By decoupling that first-party, declared health data from any private information, publishers enable brands to reach desired audiences with specific medical interests across the entire ad ecosystem—without breaking any HIPAA rules.
Digital Video Ad Performance Metrics in North America: Impression Share, by Device, Q2 2019-Q2 2020 (% of total impressions served by Extreme Reach)
Digital Video Ad Performance Metrics in North America: Video Ad Completion Rate, by Device, Q2 2019-Q2 2020 (% of total impressions served by Extreme Reach)
Do US Agencies and Brand Marketers Perceive that Select Advertising Platforms Will Be Negatively Impacted by IDFA Changes*? (% of respondents, July 2020)
How Is Co-Viewing Negotiated in Connected TV Ad Buys According to US Agency/Marketing Professionals? (% of respondents, March 2020)
Challenges Preventing Combined TV/Digital Video Ad Buying According to US Agency/Marketing Professionals, March 2020 (% of respondents)
UK Pandemic Effects: Mindful Marketing in a More Digital Post-Pandemic Landscape
Influencer Marketing in the Age of COVID-19: How Brands and Creators Are Adapting to a ‘New Normal’
How Advertisers Are Navigating Changing Auction Dynamics
How GroupM Utilizes Supply Path Optimization
The Pandemic Presents an Opportunity for Esports Viewership
The Duopoly's Share of the UK Ad Market Will Dip Below 66%